<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-04-04" modified="2020-10-07" version="183">
<accession>O60934</accession>
<accession>B2R626</accession>
<accession>B2RNC5</accession>
<accession>O60672</accession>
<accession>Q32NF7</accession>
<accession>Q53FM6</accession>
<accession>Q63HR6</accession>
<accession>Q7LDM2</accession>
<name>NBN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nibrin</fullName>
</recommendedName>
<alternativeName>
<fullName>Cell cycle regulatory protein p95</fullName>
</alternativeName>
<alternativeName>
<fullName>Nijmegen breakage syndrome protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NBN</name>
<name type="synonym">NBS</name>
<name type="synonym">NBS1</name>
<name type="synonym">P95</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Cell" volume="93" first="467" last="476">
<title>Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.</title>
<authorList>
<person name="Varon R."/>
<person name="Vissinga C."/>
<person name="Platzer M."/>
<person name="Cerosaletti K.M."/>
<person name="Chrzanowska K.H."/>
<person name="Saar K."/>
<person name="Beckmann G."/>
<person name="Seemanova E."/>
<person name="Cooper P.R."/>
<person name="Nowak N.J."/>
<person name="Stumm M."/>
<person name="Weemaes C.M.R."/>
<person name="Gatti R.A."/>
<person name="Wilson R.K."/>
<person name="Digweed M."/>
<person name="Rosenthal A."/>
<person name="Sperling K."/>
<person name="Concannon P."/>
<person name="Reis A."/>
</authorList>
<dbReference type="PubMed" id="9590180"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81174-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INVOLVEMENT IN NIJMEGEN BREAKAGE SYNDROME</scope>
<scope>VARIANT GLN-185</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Cell" volume="93" first="477" last="486">
<title>The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.</title>
<authorList>
<person name="Carney J.P."/>
<person name="Maser R.S."/>
<person name="Olivares H."/>
<person name="Davis E.M."/>
<person name="Le Beau M."/>
<person name="Yates J.R. III"/>
<person name="Hays L."/>
<person name="Morgan W.F."/>
<person name="Petrini J.H.J."/>
</authorList>
<dbReference type="PubMed" id="9590181"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81175-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 189-209; 238-250; 289-299; 300-320; 335-351; 395-405; 409-423; 426-441; 457-465; 503-529; 552-568; 595-613; 625-635; 653-660; 671-683 AND 736-745</scope>
<scope>VARIANT GLN-185</scope>
<scope>INTERACTION WITH MRE11 AND RAD50</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="179" last="181">
<title>Positional cloning of the gene for Nijmegen breakage syndrome.</title>
<authorList>
<person name="Matsuura S."/>
<person name="Tauchi H."/>
<person name="Nakamura A."/>
<person name="Kondo N."/>
<person name="Sakamoto S."/>
<person name="Endo S."/>
<person name="Smeets D."/>
<person name="Solder B."/>
<person name="Belohradsky B.H."/>
<person name="Kaloustian V.M."/>
<person name="Oshimura M."/>
<person name="Isomura M."/>
<person name="Nakamura Y."/>
<person name="Komatsu K."/>
</authorList>
<dbReference type="PubMed" id="9620777"/>
<dbReference type="DOI" id="10.1038/549"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Genomics" volume="55" first="242" last="247">
<title>Sequence analysis of an 800-kb genomic DNA region on chromosome 8q21 that contains the Nijmegen breakage syndrome gene, NBS1.</title>
<authorList>
<person name="Tauchi H."/>
<person name="Matsuura S."/>
<person name="Isomura M."/>
<person name="Kinjo T."/>
<person name="Nakamura A."/>
<person name="Sakamoto S."/>
<person name="Kondo N."/>
<person name="Endo S."/>
<person name="Komatsu K."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="9933573"/>
<dbReference type="DOI" id="10.1006/geno.1998.5657"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT GLN-185</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Synovial cell</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2004-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ASN-105; GLN-185; LYS-216; LEU-266 AND ALA-497</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Skin</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 58-754</scope>
<source>
<tissue>Colon endothelium</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="21447" last="21450">
<title>Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95.</title>
<authorList>
<person name="Trujillo K.M."/>
<person name="Yuan S.-S.F."/>
<person name="Lee E.Y.-H.P."/>
<person name="Sung P."/>
</authorList>
<dbReference type="PubMed" id="9705271"/>
<dbReference type="DOI" id="10.1074/jbc.273.34.21447"/>
</citation>
<scope>FUNCTION IN DSB REPAIR</scope>
<scope>IDENTIFICATION IN THE MRN COMPLEX WITH MRE11 AND RAD50</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="927" last="939">
<title>BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.</title>
<authorList>
<person name="Wang Y."/>
<person name="Cortez D."/>
<person name="Yazdi P."/>
<person name="Neff N."/>
<person name="Elledge S.J."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="10783165"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION IN THE BASC COMPLEX WITH BRCA1; MSH2; MSH6; MLH1; ATM; BLM; RAD50 AND MRE11</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="2184" last="2191">
<title>Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localization.</title>
<authorList>
<person name="Desai-Mehta A."/>
<person name="Cerosaletti K.M."/>
<person name="Concannon P."/>
</authorList>
<dbReference type="PubMed" id="11238951"/>
<dbReference type="DOI" id="10.1128/mcb.21.6.2184-2191.2001"/>
</citation>
<scope>INTERACTION WITH MRE11</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="115" last="119">
<title>ATM-dependent phosphorylation of nibrin in response to radiation exposure.</title>
<authorList>
<person name="Gatei M."/>
<person name="Young D."/>
<person name="Cerosaletti K.M."/>
<person name="Desai-Mehta A."/>
<person name="Spring K."/>
<person name="Kozlov S."/>
<person name="Lavin M.F."/>
<person name="Gatti R.A."/>
<person name="Concannon P."/>
<person name="Khanna K.K."/>
</authorList>
<dbReference type="PubMed" id="10802669"/>
<dbReference type="DOI" id="10.1038/75508"/>
</citation>
<scope>PHOSPHORYLATION AT SER-343</scope>
<scope>MUTAGENESIS OF ARG-28; HIS-45; 136-GLY-GLY-137 AND TYR-176</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Nature" volume="405" first="473" last="477">
<title>Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.</title>
<authorList>
<person name="Zhao S."/>
<person name="Weng Y.-C."/>
<person name="Yuan S.-S.F."/>
<person name="Lin Y.-T."/>
<person name="Hsu H.-C."/>
<person name="Lin S.-C."/>
<person name="Gerbino E."/>
<person name="Song M.-H."/>
<person name="Zdzienicka M.Z."/>
<person name="Gatti R.A."/>
<person name="Shay J.W."/>
<person name="Ziv Y."/>
<person name="Shiloh Y."/>
<person name="Lee E.Y.-H.P."/>
</authorList>
<dbReference type="PubMed" id="10839544"/>
<dbReference type="DOI" id="10.1038/35013083"/>
</citation>
<scope>PHOSPHORYLATION AT SER-278</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Nature" volume="405" first="477" last="482">
<title>ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.</title>
<authorList>
<person name="Wu X."/>
<person name="Ranganathan V."/>
<person name="Weisman D.S."/>
<person name="Heine W.F."/>
<person name="Ciccone D.N."/>
<person name="O'Neill T.B."/>
<person name="Crick K.E."/>
<person name="Pierce K.A."/>
<person name="Lane W.S."/>
<person name="Rathbun G."/>
<person name="Livingston D.M."/>
<person name="Weaver D.T."/>
</authorList>
<dbReference type="PubMed" id="10839545"/>
<dbReference type="DOI" id="10.1038/35013089"/>
</citation>
<scope>PHOSPHORYLATION AT SER-343; SER-397 AND SER-615</scope>
<scope>MUTAGENESIS OF SER-343; SER-397 AND SER-615</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="347" last="352">
<title>Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres.</title>
<authorList>
<person name="Zhu X.-D."/>
<person name="Kuester B."/>
<person name="Mann M."/>
<person name="Petrini J.H.J."/>
<person name="de Lange T."/>
</authorList>
<dbReference type="PubMed" id="10888888"/>
<dbReference type="DOI" id="10.1038/77139"/>
</citation>
<scope>FUNCTION IN TELOMERES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH TERF2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="299" first="863" last="871">
<title>Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein.</title>
<authorList>
<person name="Naka K."/>
<person name="Ikeda K."/>
<person name="Motoyama N."/>
</authorList>
<dbReference type="PubMed" id="12470659"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)02755-9"/>
</citation>
<scope>INTERACTION WITH SP100</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="1846" last="1851">
<title>NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.</title>
<authorList>
<person name="Kobayashi J."/>
<person name="Tauchi H."/>
<person name="Sakamoto S."/>
<person name="Nakamura A."/>
<person name="Morishima K."/>
<person name="Matsuura S."/>
<person name="Kobayashi T."/>
<person name="Tamai K."/>
<person name="Tanimoto K."/>
<person name="Komatsu K."/>
</authorList>
<dbReference type="PubMed" id="12419185"/>
<dbReference type="DOI" id="10.1016/s0960-9822(02)01259-9"/>
</citation>
<scope>INTERACTION WITH H2AX</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="39594" last="39600">
<title>Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1.</title>
<authorList>
<person name="Tseng S.-F."/>
<person name="Chang C.-Y."/>
<person name="Wu K.-J."/>
<person name="Teng S.-C."/>
</authorList>
<dbReference type="PubMed" id="16188882"/>
<dbReference type="DOI" id="10.1074/jbc.m508425200"/>
</citation>
<scope>INTERACTION WITH KPNA2</scope>
<scope>MUTAGENESIS OF SER-397; 465-LYS-ARG-466 AND GLN-583</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Mol. Cell" volume="18" first="577" last="587">
<title>ATM-dependent phosphorylation of ATF2 is required for the DNA damage response.</title>
<authorList>
<person name="Bhoumik A."/>
<person name="Takahashi S."/>
<person name="Breitweiser W."/>
<person name="Shiloh Y."/>
<person name="Jones N."/>
<person name="Ronai Z."/>
</authorList>
<dbReference type="PubMed" id="15916964"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.04.015"/>
</citation>
<scope>INTERACTION WITH ATF2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Nature" volume="434" first="605" last="611">
<title>Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.</title>
<authorList>
<person name="Falck J."/>
<person name="Coates J."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="15758953"/>
<dbReference type="DOI" id="10.1038/nature03442"/>
</citation>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF 736-GLU-GLU-737; 741-ASP-ASP-742 AND 745-ARG-TYR-746</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="199" last="208">
<title>Nbs1 is required for ATR-dependent phosphorylation events.</title>
<authorList>
<person name="Stiff T."/>
<person name="Reis C."/>
<person name="Alderton G.K."/>
<person name="Woodbine L."/>
<person name="O'Driscoll M."/>
<person name="Jeggo P.A."/>
</authorList>
<dbReference type="PubMed" id="15616588"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600504"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Cell Res." volume="16" first="45" last="54">
<title>The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint control.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Zhou J."/>
<person name="Lim C.U."/>
</authorList>
<dbReference type="PubMed" id="16467875"/>
<dbReference type="DOI" id="10.1038/sj.cr.7310007"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Nature" volume="418" first="348" last="352">
<title>Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.</title>
<authorList>
<person name="Stracker T.H."/>
<person name="Carson C.T."/>
<person name="Weitzman M.D."/>
</authorList>
<dbReference type="PubMed" id="12124628"/>
<dbReference type="DOI" id="10.1038/nature00863"/>
</citation>
<scope>INACTIVATION BY ADENOVIRUS ONCOPROTEINS</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="8544" last="8553">
<title>Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells.</title>
<authorList>
<person name="Kato T."/>
<person name="Sato N."/>
<person name="Hayama S."/>
<person name="Yamabuki T."/>
<person name="Ito T."/>
<person name="Miyamoto M."/>
<person name="Kondo S."/>
<person name="Nakamura Y."/>
<person name="Daigo Y."/>
</authorList>
<dbReference type="PubMed" id="17823411"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-1307"/>
</citation>
<scope>INTERACTION WITH HJURP</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397 AND SER-432</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="31746" last="31752">
<title>N terminus of CtIP is critical for homologous recombination-mediated double-strand break repair.</title>
<authorList>
<person name="Yuan J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19759395"/>
<dbReference type="DOI" id="10.1074/jbc.m109.023424"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RBBP8</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Mol. Cell" volume="35" first="384" last="393">
<title>SOSS complexes participate in the maintenance of genomic stability.</title>
<authorList>
<person name="Huang J."/>
<person name="Gong Z."/>
<person name="Ghosal G."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19683501"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.06.011"/>
</citation>
<scope>INTERACTION WITH INTS3</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="12504" last="12514">
<title>Physical interaction between the herpes simplex virus type 1 exonuclease, UL12, and the DNA double-strand break-sensing MRN complex.</title>
<authorList>
<person name="Balasubramanian N."/>
<person name="Bai P."/>
<person name="Buchek G."/>
<person name="Korza G."/>
<person name="Weller S.K."/>
</authorList>
<dbReference type="PubMed" id="20943970"/>
<dbReference type="DOI" id="10.1128/jvi.01506-10"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL12 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397; THR-402 AND SER-432</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-337; SER-343; SER-347; SER-397; SER-432; SER-509; SER-518 AND SER-673</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E65586" last="E65586">
<title>Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains.</title>
<authorList>
<person name="Wang J.Q."/>
<person name="Chen J.H."/>
<person name="Chen Y.C."/>
<person name="Chen M.Y."/>
<person name="Hsieh C.Y."/>
<person name="Teng S.C."/>
<person name="Wu K.J."/>
</authorList>
<dbReference type="PubMed" id="23762398"/>
<dbReference type="DOI" id="10.1371/journal.pone.0065586"/>
</citation>
<scope>FUNCTION IN AKT1 PHOSPHORYLATION</scope>
<scope>INTERACTION WITH MTOR; MAPKAP1 AND RICTOR</scope>
<scope>INDUCTION BY IONIZING RADIATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="7744" last="7744">
<title>MCM8-9 complex promotes resection of double-strand break ends by MRE11-RAD50-NBS1 complex.</title>
<authorList>
<person name="Lee K.Y."/>
<person name="Im J.S."/>
<person name="Shibata E."/>
<person name="Park J."/>
<person name="Handa N."/>
<person name="Kowalczykowski S.C."/>
<person name="Dutta A."/>
</authorList>
<dbReference type="PubMed" id="26215093"/>
<dbReference type="DOI" id="10.1038/ncomms8744"/>
</citation>
<scope>IDENTIFICATION IN THE MRN COMPLEX</scope>
<scope>INTERACTION WITH MCM9</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2016" name="Cell Rep." volume="16" first="2565" last="2575">
<title>MRNIP/C5orf45 interacts with the MRN complex and contributes to the DNA damage response.</title>
<authorList>
<person name="Staples C.J."/>
<person name="Barone G."/>
<person name="Myers K.N."/>
<person name="Ganesh A."/>
<person name="Gibbs-Seymour I."/>
<person name="Patil A.A."/>
<person name="Beveridge R.D."/>
<person name="Daye C."/>
<person name="Beniston R."/>
<person name="Maslen S."/>
<person name="Ahel I."/>
<person name="Skehel J.M."/>
<person name="Collis S.J."/>
</authorList>
<dbReference type="PubMed" id="27568553"/>
<dbReference type="DOI" id="10.1016/j.celrep.2016.07.087"/>
</citation>
<scope>INTERACTION WITH MRNIP</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-529; LYS-571 AND LYS-582</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2019" name="Nat. Commun." volume="10" first="1242" last="1242">
<title>UFL1 promotes histone H4 ufmylation and ATM activation.</title>
<authorList>
<person name="Qin B."/>
<person name="Yu J."/>
<person name="Nowsheen S."/>
<person name="Wang M."/>
<person name="Tu X."/>
<person name="Liu T."/>
<person name="Li H."/>
<person name="Wang L."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="30886146"/>
<dbReference type="DOI" id="10.1038/s41467-019-09175-0"/>
</citation>
<scope>INTERACTION WITH UFL1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="3570" last="3572">
<title>Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).</title>
<authorList>
<person name="Varon R."/>
<person name="Reis A."/>
<person name="Henze G."/>
<person name="von Einsiedel H.G."/>
<person name="Sperling K."/>
<person name="Seeger K."/>
</authorList>
<dbReference type="PubMed" id="11325820"/>
</citation>
<scope>VARIANTS LEU-93; ASN-95; VAL-171; PHE-210 AND TRP-215</scope>
<scope>POSSIBLE INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="E131" last="E131">
<title>Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.</title>
<authorList>
<person name="Heikkinen K."/>
<person name="Karppinen S.-M."/>
<person name="Soini Y."/>
<person name="Maekinen M."/>
<person name="Winqvist R."/>
</authorList>
<dbReference type="PubMed" id="14684699"/>
<dbReference type="DOI" id="10.1136/jmg.40.12.e131"/>
</citation>
<scope>VARIANT BC PHE-150</scope>
<scope>VARIANTS GLN-185 AND ILE-574</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2004" name="Carcinogenesis" volume="25" first="729" last="734">
<title>Polymorphisms in DNA repair and metabolic genes in bladder cancer.</title>
<authorList>
<person name="Sanyal S."/>
<person name="Festa F."/>
<person name="Sakano S."/>
<person name="Zhang Z."/>
<person name="Steineck G."/>
<person name="Norming U."/>
<person name="Wijkstroem H."/>
<person name="Larsson P."/>
<person name="Kumar R."/>
<person name="Hemminki K."/>
</authorList>
<dbReference type="PubMed" id="14688016"/>
<dbReference type="DOI" id="10.1093/carcin/bgh058"/>
</citation>
<scope>VARIANT GLN-185</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2004" name="Hum. Genet." volume="115" first="372" last="376">
<title>First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability.</title>
<authorList>
<person name="Shimada H."/>
<person name="Shimizu K."/>
<person name="Mimaki S."/>
<person name="Sakiyama T."/>
<person name="Mori T."/>
<person name="Shimasaki N."/>
<person name="Yokota J."/>
<person name="Nakachi K."/>
<person name="Ohta T."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="15338273"/>
<dbReference type="DOI" id="10.1007/s00439-004-1155-1"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN AA</scope>
<scope>VARIANT VAL-171</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Nature" volume="469" first="539" last="542">
<title>Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.</title>
<authorList>
<person name="Varela I."/>
<person name="Tarpey P."/>
<person name="Raine K."/>
<person name="Huang D."/>
<person name="Ong C.K."/>
<person name="Stephens P."/>
<person name="Davies H."/>
<person name="Jones D."/>
<person name="Lin M.L."/>
<person name="Teague J."/>
<person name="Bignell G."/>
<person name="Butler A."/>
<person name="Cho J."/>
<person name="Dalgliesh G.L."/>
<person name="Galappaththige D."/>
<person name="Greenman C."/>
<person name="Hardy C."/>
<person name="Jia M."/>
<person name="Latimer C."/>
<person name="Lau K.W."/>
<person name="Marshall J."/>
<person name="McLaren S."/>
<person name="Menzies A."/>
<person name="Mudie L."/>
<person name="Stebbings L."/>
<person name="Largaespada D.A."/>
<person name="Wessels L.F.A."/>
<person name="Richard S."/>
<person name="Kahnoski R.J."/>
<person name="Anema J."/>
<person name="Tuveson D.A."/>
<person name="Perez-Mancera P.A."/>
<person name="Mustonen V."/>
<person name="Fischer A."/>
<person name="Adams D.J."/>
<person name="Rust A."/>
<person name="Chan-On W."/>
<person name="Subimerb C."/>
<person name="Dykema K."/>
<person name="Furge K."/>
<person name="Campbell P.J."/>
<person name="Teh B.T."/>
<person name="Stratton M.R."/>
<person name="Futreal P.A."/>
</authorList>
<dbReference type="PubMed" id="21248752"/>
<dbReference type="DOI" id="10.1038/nature09639"/>
</citation>
<scope>VARIANT HIS-679</scope>
</reference>
<comment type="function">
<text evidence="15 24 30 33 39">Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability. Forms a complex with RBBP8 to link DNA double-strand break sensing to resection. Enhances AKT1 phosphorylation possibly by association with the mTORC2 complex.</text>
</comment>
<comment type="subunit">
<text evidence="11 15 16 18 19 26 27 28 29 30 33 34 35 36 38 39">Component of the MRN complex composed of two heterodimers RAD50/MRE11 associated with a single NBN (PubMed:26215093, PubMed:9590181, PubMed:9705271, PubMed:11238951). As part of the MRN complex, interacts with MCM9; the interaction recruits the complex to DNA repair sites (PubMed:26215093). Component of the BASC complex, at least composed of BRCA1, MSH2, MSH6, MLH1, ATM, BLM, RAD50, MRE11 and NBN (PubMed:10783165). Interacts with histone H2AX this requires phosphorylation of H2AX on 'Ser-139' (PubMed:12419185). Interacts with HJURP (PubMed:17823411). Interacts with INTS3 (PubMed:19683501). Interacts with KPNA2 (PubMed:16188882). Interacts with TERF2 (PubMed:10888888). Interacts with RBBP8; the interaction links the role of the MRN complex in DNA double-strand break sensing to resection (PubMed:19759395). Interacts with SP100; recruits NBN to PML bodies (PubMed:12470659). Interacts with ATF2 (PubMed:15916964). Interacts with MTOR, MAPKAP1 isoform 2 and RICTOR; indicative for an association with the mTORC2 complex (PubMed:23762398). Interacts with MRNIP (PubMed:27568553). Interacts with UFL1; promoting UFL1 recruitment to double-strand breaks following DNA damage (PubMed:30886146).</text>
</comment>
<comment type="subunit">
<text evidence="31">(Microbial infection) Interacts with herpes simplex virus 1 protein UL12.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-495465">
<id>Q13315</id>
<label>ATM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-359343">
<id>Q9BXW9</id>
<label>FANCD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-494830">
<id>P16104</id>
<label>H2AX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-2680854">
<id>Q68E01</id>
<label>INTS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-495644">
<id>Q14676</id>
<label>MDC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>33</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-396513">
<id>P49959</id>
<label>MRE11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-968231">
<id>O75943</id>
<label>RAD17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-745715">
<id>Q99708</id>
<label>RBBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-396105">
<id>Q13428</id>
<label>TCOF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494844">
<id>O60934</id>
</interactant>
<interactant intactId="EBI-1769146">
<id>Q99986</id>
<label>VRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 34">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 26">Nucleus</location>
<location evidence="19 26">PML body</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Chromosome</location>
<location evidence="15">Telomere</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="34">Chromosome</location>
</subcellularLocation>
<text evidence="11 34">Localizes to discrete nuclear foci after treatment with genotoxic agents.</text>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous. Expressed at high levels in testis.</text>
</comment>
<comment type="induction">
<text evidence="33">Up-regulated by ionizing radiation (IR).</text>
</comment>
<comment type="domain">
<text evidence="25">The FHA and BRCT domains are likely to have a crucial role for both binding to histone H2AX and for relocalization of MRE11/RAD50 complex to the vicinity of DNA damage.</text>
</comment>
<comment type="domain">
<text evidence="25">The C-terminal domain contains a MRE11-binding site, and this interaction is required for the nuclear localization of the MRN complex.</text>
</comment>
<comment type="domain">
<text evidence="25">The EEXXXDDL motif at the C-terminus is required for the interaction with ATM and its recruitment to sites of DNA damage and promote the phosphorylation of ATM substrates, leading to the events of DNA damage response.</text>
</comment>
<comment type="PTM">
<text evidence="12 13 14">Phosphorylated by ATM in response of ionizing radiation, and such phosphorylation is responsible intra-S phase checkpoint control and telomere maintenance.</text>
</comment>
<comment type="disease" evidence="37">
<disease id="DI-02058">
<name>Nijmegen breakage syndrome</name>
<acronym>NBS</acronym>
<description>A disorder characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, immunodeficiency and predisposition to cancer, particularly to lymphoid malignancies.</description>
<dbReference type="MIM" id="251260"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="20">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-02842">
<name>Aplastic anemia</name>
<acronym>AA</acronym>
<description>A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. It is characterized by peripheral pancytopenia and marrow hypoplasia.</description>
<dbReference type="MIM" id="609135"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="17">Defects in NBN might play a role in the pathogenesis of childhood acute lymphoblastic leukemia (ALL).</text>
</comment>
<comment type="miscellaneous">
<text>In case of infection by adenovirus E4, the MRN complex is inactivated and degraded by viral oncoproteins, thereby preventing concatenation of viral genomes in infected cells.</text>
</comment>
<comment type="sequence caution" evidence="41">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAI08651" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence starting in position 550.</text>
</comment>
<comment type="sequence caution" evidence="41">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAH56160" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NBS1ID160.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/nbs1/"/>
</comment>
<dbReference type="EMBL" id="AF051334">
<property type="protein sequence ID" value="AAC39732.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF058696">
<property type="protein sequence ID" value="AAC39752.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB013139">
<property type="protein sequence ID" value="BAA28616.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF069291">
<property type="protein sequence ID" value="AAC62232.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312410">
<property type="protein sequence ID" value="BAG35323.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223256">
<property type="protein sequence ID" value="BAD96976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY566246">
<property type="protein sequence ID" value="AAS59158.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471060">
<property type="protein sequence ID" value="EAW91660.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC108650">
<property type="protein sequence ID" value="AAI08651.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136802">
<property type="protein sequence ID" value="AAI36803.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136803">
<property type="protein sequence ID" value="AAI36804.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX640816">
<property type="protein sequence ID" value="CAH56160.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6249.1"/>
<dbReference type="PIR" id="T00393">
<property type="entry name" value="T00393"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001019859.1">
<property type="nucleotide sequence ID" value="NM_001024688.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002476.2">
<property type="nucleotide sequence ID" value="NM_002485.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011515347.1">
<property type="nucleotide sequence ID" value="XM_011517045.1"/>
</dbReference>
<dbReference type="PDB" id="5WQD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="H/I/J/K/L/M/N=423-438"/>
</dbReference>
<dbReference type="PDBsum" id="5WQD"/>
<dbReference type="SMR" id="O60934"/>
<dbReference type="BioGRID" id="110763">
<property type="interactions" value="123"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4442">
<property type="entry name" value="MRN complex"/>
</dbReference>
<dbReference type="CORUM" id="O60934"/>
<dbReference type="DIP" id="DIP-33605N"/>
<dbReference type="ELM" id="O60934"/>
<dbReference type="IntAct" id="O60934">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="MINT" id="O60934"/>
<dbReference type="STRING" id="9606.ENSP00000265433"/>
<dbReference type="iPTMnet" id="O60934"/>
<dbReference type="MetOSite" id="O60934"/>
<dbReference type="PhosphoSitePlus" id="O60934"/>
<dbReference type="BioMuta" id="NBN"/>
<dbReference type="CPTAC" id="CPTAC-3236"/>
<dbReference type="CPTAC" id="CPTAC-3237"/>
<dbReference type="CPTAC" id="CPTAC-3238"/>
<dbReference type="CPTAC" id="CPTAC-3239"/>
<dbReference type="CPTAC" id="CPTAC-934"/>
<dbReference type="CPTAC" id="CPTAC-935"/>
<dbReference type="EPD" id="O60934"/>
<dbReference type="jPOST" id="O60934"/>
<dbReference type="MassIVE" id="O60934"/>
<dbReference type="MaxQB" id="O60934"/>
<dbReference type="PaxDb" id="O60934"/>
<dbReference type="PeptideAtlas" id="O60934"/>
<dbReference type="PRIDE" id="O60934"/>
<dbReference type="ProteomicsDB" id="49678"/>
<dbReference type="Antibodypedia" id="690">
<property type="antibodies" value="1464 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="O60934">
<property type="antibodies" value="4 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000265433">
<property type="protein sequence ID" value="ENSP00000265433"/>
<property type="gene ID" value="ENSG00000104320"/>
</dbReference>
<dbReference type="GeneID" id="4683"/>
<dbReference type="KEGG" id="hsa:4683"/>
<dbReference type="UCSC" id="uc003yej.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4683"/>
<dbReference type="DisGeNET" id="4683"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000104320.13"/>
<dbReference type="GeneCards" id="NBN"/>
<dbReference type="GeneReviews" id="NBN"/>
<dbReference type="HGNC" id="HGNC:7652">
<property type="gene designation" value="NBN"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000104320">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NBN"/>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="251260">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="602667">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="609135">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60934"/>
<dbReference type="OpenTargets" id="ENSG00000104320"/>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="647">
<property type="disease" value="Nijmegen breakage syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31457"/>
<dbReference type="eggNOG" id="ENOG502QQ7Y">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000000521"/>
<dbReference type="HOGENOM" id="CLU_023410_0_0_1"/>
<dbReference type="InParanoid" id="O60934"/>
<dbReference type="KO" id="K10867"/>
<dbReference type="OMA" id="NFGVFES"/>
<dbReference type="OrthoDB" id="831679at2759"/>
<dbReference type="PhylomeDB" id="O60934"/>
<dbReference type="TreeFam" id="TF101103"/>
<dbReference type="PathwayCommons" id="O60934"/>
<dbReference type="Reactome" id="R-HSA-2559586">
<property type="pathway name" value="DNA Damage/Telomere Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685939">
<property type="pathway name" value="HDR through MMEJ (alt-NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693548">
<property type="pathway name" value="Sensing of DNA Double Strand Breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="SIGNOR" id="O60934"/>
<dbReference type="BioGRID-ORCS" id="4683">
<property type="hits" value="19 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NBN">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Nibrin"/>
<dbReference type="GenomeRNAi" id="4683"/>
<dbReference type="Pharos" id="O60934">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O60934"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="RNAct" id="O60934">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000104320">
<property type="expression patterns" value="Expressed in endometrium epithelium and 257 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O60934">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O60934">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030870">
<property type="term" value="C:Mre11 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042405">
<property type="term" value="C:nuclear inclusion body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005657">
<property type="term" value="C:replication fork"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035861">
<property type="term" value="C:site of double-strand break"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001832">
<property type="term" value="P:blastocyst growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030330">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000729">
<property type="term" value="P:DNA double-strand break processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032508">
<property type="term" value="P:DNA duplex unwinding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006303">
<property type="term" value="P:double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097193">
<property type="term" value="P:intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045190">
<property type="term" value="P:isotype switching"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051321">
<property type="term" value="P:meiotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007093">
<property type="term" value="P:mitotic cell cycle checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007095">
<property type="term" value="P:mitotic G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904354">
<property type="term" value="P:negative regulation of telomere capping"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050885">
<property type="term" value="P:neuromuscular process controlling balance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033674">
<property type="term" value="P:positive regulation of kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031954">
<property type="term" value="P:positive regulation of protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032206">
<property type="term" value="P:positive regulation of telomere maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030174">
<property type="term" value="P:regulation of DNA-dependent DNA replication initiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042770">
<property type="term" value="P:signal transduction in response to DNA damage"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0090656">
<property type="term" value="P:t-circle formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016233">
<property type="term" value="P:telomere capping"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000723">
<property type="term" value="P:telomere maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090737">
<property type="term" value="P:telomere maintenance via telomere trimming"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031860">
<property type="term" value="P:telomeric 3' overhang formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00060">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10980">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013908">
<property type="entry name" value="DNA-repair_Nbs1_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000253">
<property type="entry name" value="FHA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR040227">
<property type="entry name" value="Nibrin-rel"/>
</dbReference>
<dbReference type="InterPro" id="IPR032429">
<property type="entry name" value="Nibrin_BRCT2"/>
</dbReference>
<dbReference type="InterPro" id="IPR043014">
<property type="entry name" value="Nibrin_BRCT2_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016592">
<property type="entry name" value="Nibrin_met"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12162">
<property type="entry name" value="PTHR12162"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00498">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08599">
<property type="entry name" value="Nbs1_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16508">
<property type="entry name" value="NIBRIN_BRCT_II"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF011869">
<property type="entry name" value="Nibrin_animal"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00240">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01348">
<property type="entry name" value="Nbs1_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50006">
<property type="entry name" value="FHA_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0469">Meiosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0779">Telomere</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Nibrin" id="PRO_0000231043">
<location>
<begin position="1"/>
<end position="754"/>
</location>
</feature>
<feature type="domain" description="FHA" evidence="10">
<location>
<begin position="24"/>
<end position="83"/>
</location>
</feature>
<feature type="domain" description="BRCT">
<location>
<begin position="105"/>
<end position="181"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with SP100" evidence="9">
<location>
<begin position="111"/>
<end position="328"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MTOR, MAPKAP1 and RICTOR" evidence="33">
<location>
<begin position="221"/>
<end position="402"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="461"/>
<end position="467"/>
</location>
</feature>
<feature type="short sequence motif" description="EEXXXDDL motif">
<location>
<begin position="736"/>
<end position="743"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="448"/>
<end position="451"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="13">
<location>
<position position="278"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="337"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="6 12 14">
<location>
<position position="343"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="347"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5 6 14">
<location>
<position position="397"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="402"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 5 6 7">
<location>
<position position="432"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="509"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="518"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="673"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="529"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="571"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In some childhood acute lymphoblastic leukemia patients; uncertain pathological significance; rare variant; dbSNP:rs12721593." id="VAR_025792" evidence="17">
<original>S</original>
<variation>L</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In some childhood acute lymphoblastic leukemia patients; uncertain pathological significance; rare variant; dbSNP:rs61753720." id="VAR_025793" evidence="17">
<original>D</original>
<variation>N</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13312858." id="VAR_025794" evidence="40">
<original>K</original>
<variation>N</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs769414." id="VAR_051226">
<original>N</original>
<variation>S</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs773119929." id="VAR_025795" evidence="20">
<original>L</original>
<variation>F</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In some childhood acute lymphoblastic leukemia patients; uncertain pathological significance; rare variant; associated with aplastic anemia at homozygosity; dbSNP:rs61754966." id="VAR_025796" evidence="17 23">
<original>I</original>
<variation>V</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1805794." id="VAR_025797" evidence="20 21 22 37 38 40">
<original>E</original>
<variation>Q</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61754796." id="VAR_025798" evidence="17">
<original>V</original>
<variation>F</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34767364." id="VAR_025799" evidence="17">
<original>R</original>
<variation>W</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs769416." id="VAR_025800" evidence="40">
<original>Q</original>
<variation>K</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs769420." id="VAR_025801" evidence="40">
<original>P</original>
<variation>L</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34120922." id="VAR_051227">
<original>K</original>
<variation>E</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3026268." id="VAR_025802" evidence="40">
<original>T</original>
<variation>A</variation>
<location>
<position position="497"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs142334798." id="VAR_025803" evidence="20">
<original>L</original>
<variation>I</variation>
<location>
<position position="574"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a renal cell carcinoma sample; somatic mutation." id="VAR_064738" evidence="32">
<original>Y</original>
<variation>H</variation>
<location>
<position position="679"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation." evidence="12">
<original>R</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation." evidence="12">
<original>H</original>
<variation>A</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation." evidence="12">
<original>GG</original>
<variation>EE</variation>
<location>
<begin position="136"/>
<end position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ATM-dependent phosphorylation." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ATM-dependent phosphorylation. No loss of interaction with KPNA2." evidence="14 27">
<original>S</original>
<variation>A</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks the association with KPNA2, and reduces nuclear foci formation in response to ionizing radiation." evidence="27">
<original>KR</original>
<variation>AA</variation>
<location>
<begin position="465"/>
<end position="466"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of interaction with KPNA2." evidence="27">
<original>Q</original>
<variation>K</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ATM-dependent phosphorylation." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="615"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ATM binding." evidence="25">
<original>EE</original>
<variation>AA</variation>
<location>
<begin position="736"/>
<end position="737"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ATM binding." evidence="25">
<original>DD</original>
<variation>AA</variation>
<location>
<begin position="741"/>
<end position="742"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ATM binding." evidence="25">
<original>RY</original>
<variation>AA</variation>
<location>
<begin position="745"/>
<end position="746"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAD96976." ref="6" evidence="41">
<original>G</original>
<variation>R</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="426"/>
<end position="429"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WQD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00086"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10783165"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10802669"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10839544"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10839545"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10888888"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11238951"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11325820"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12419185"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12470659"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684699"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14688016"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15338273"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15616588"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15758953"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15916964"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16188882"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17823411"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19683501"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19759395"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20943970"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21248752"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23762398"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26215093"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27568553"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30886146"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9590180"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9590181"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9705271"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<sequence length="754" mass="84959" checksum="CD602F09BA73DAB6" modified="1998-08-01" version="1">MWKLLPAAGPAGGEPYRLLTGVEYVVGRKNCAILIENDQSISRNHAVLTANFSVTNLSQTDEIPVLTLKDNSKYGTFVNEEKMQNGFSRTLKSGDGITFGVFGSKFRIEYEPLVACSSCLDVSGKTALNQAILQLGGFTVNNWTEECTHLVMVSVKVTIKTICALICGRPIVKPEYFTEFLKAVESKKQPPQIESFYPPLDEPSIGSKNVDLSGRQERKQIFKGKTFIFLNAKQHKKLSSAVVFGGGEARLITEENEEEHNFFLAPGTCVVDTGITNSQTLIPDCQKKWIQSIMDMLQRQGLRPIPEAEIGLAVIFMTTKNYCDPQGHPSTGLKTTTPGPSLSQGVSVDEKLMPSAPVNTTTYVADTESEQADTWDLSERPKEIKVSKMEQKFRMLSQDAPTVKESCKTSSNNNSMVSNTLAKMRIPNYQLSPTKLPSINKSKDRASQQQQTNSIRNYFQPSTKKRERDEENQEMSSCKSARIETSCSLLEQTQPATPSLWKNKEQHLSENEPVDTNSDNNLFTDTDLKSIVKNSASKSHAAEKLRSNKKREMDDVAIEDEVLEQLFKDTKPELEIDVKVQKQEEDVNVRKRPRMDIETNDTFSDEAVPESSKISQENEIGKKRELKEDSLWSAKEISNNDKLQDDSEMLPKKLLLTEFRSLVIKNSTSRNPSGINDDYGQLKNFKKFKKVTYPGAGKLPHIIGGSDLIAHHARKNTELEEWLRQEMEVQNQHAKEESLADDLFRYNPYLKRRR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

